CLINICAL_TRIALS
trial_result
· 2024-01-30
Clinical Trial Update: MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation [Phase 2]
Summary
Phase 2 clinical trial evaluating intravenous ferumoxytol imaging in CNS inflammation has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oregon Health and Science University | Conditions: Nervous System Diseases, Diagnostic Imaging | Phase 2 | Status: TERMINATED | Results posted: 2024-01-30